Jean‐Pierre Falgueyret

The discovery of odanacatib (MK-0822), a selective inhibitor of cathepsin K

Jacques Yves Gauthier, Nathalie Chauret, Wanda Cromlish et al. · Bioorganic & Medicinal Chemistry Letters · 2008 · 473 citations · Full text

Pharmacy, Medicinal Chemistry, Pharmacology +10

Etoricoxib (MK-0663): Preclinical Profile and Comparison with Other Agents That Selectively Inhibit Cyclooxygenase-2

Denis Riendeau, M. David Percival, Christine Brideau et al. · Journal of Pharmacology and Experimental Therapeutics · 2001 · 460 citations · Full text

Medicine, Medicinal Chemistry, Pharmacology +13

Quinolines as potent 5-lipoxygenase inhibitors: Synthesis and biological profile of L-746,530

Daniel Dubé, Marc Blouin, Christine Brideau et al. · Bioorganic & Medicinal Chemistry Letters · 1998 · 272 citations · Full text

Medicine, Medicinal Chemistry, Pharmacology +11

Reconstitution of a 10-gene pathway for synthesis of the plant alkaloid dihydrosanguinarine in Saccharomyces cerevisiae

Elena Fossati, Andrew Ekins, Lauren Narcross et al. · Nature Communications · 2014 · 186 citations · Full text

Life Sciences, Biochemistry, Molecular Biology +16

Overexpression of human prostaglandin G/H synthase-1 and -2 by recombinant vaccinia virus: inhibition by nonsteroidal anti-inflammatory drugs and biosynthesis of 15-hydroxyeicosatetraenoic acid.

Gary P. O’Neill, Joseph A. Mancini, Stacia Kargman et al. · Molecular Pharmacology · 1994 · 183 citations

Life Sciences, Biochemistry, Molecular Biology +13